Akari Therapeutics Plc (AKTX) Operating cash flow 2016–2025
Akari Therapeutics Plc (AKTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.6MFY2025 · since FY2016: -$24.6M → -$10.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.6M | +15.8% |
| FY2024 | -$12.6M | +23.6% |
| FY2023 | -$16.4M | +23.6% |
| FY2022 | -$21.5M | -14.1% |
| FY2021 | -$18.8M | -11.2% |
| FY2020 | -$17.0M | -31.2% |
| FY2019 | -$12.9M | +43.3% |
| FY2018 | -$22.8M | +27.9% |
| FY2017 | -$31.6M | -28.3% |
| FY2016 | -$24.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AKTX financial trends
AKTX RevenueAKTX Net incomeAKTX Net marginAKTX Gross profitAKTX Gross marginAKTX Operating incomeAKTX Operating marginAKTX Free cash flowAKTX Capital expendituresAKTX Return on equityAKTX Stock buybacksAKTX Dividends paidAKTX Total assetsAKTX Total liabilitiesAKTX Shareholders’ equityAKTX overview →